Cirmaxon Trademark Details

This mark is dead with a status of Abandoned - No Statement of Use Filed. The last case file activity for this mark occured 16 years ago on Thursday, May 15, 2008, according to the United State Patent & Trademark Office
Word Mark Cirmaxon
Status Dead 606 — Abandoned - No Statement of Use Filed

Current Owner

Forest Laboratories, Inc. of New York, NY

View all trademarks for Forest Laboratories, Inc.
Other Trademarks for Forest Laboratories, Inc.
Serial Number 78833810
Status Date Thursday, May 15, 2008
Filing Date Thursday, May 15, 2008
Attorney Christopher Serbagi

Correspondent

Christopher Serbagi
LAW OFFICES OF CHRISTOPHER SERBAGI
488 MADISON AVENUE
SUITE 1120
NEW YORK NY 10022

Case File Statements

Goods & Services Pharmaceutical preparations for the treatment of Hypertension, Isolated Systolic Hypertension, Essential Hypertension, Hypertension with Renal Disease, Primary Pulmonary Hypertension, Hypertension Encephalopathy, Congestive Heart Failure, Diastolic Heart Failure, Peripheral Vascular Disease, Left Ventricular Dysfunction following Myocardial Infarction, Definite or Suspected Acute Myocardial Infarction, Angina Pectoris, Chest Pain, Neuropathy in Type II Diabetics, Treatment of Endothelial Dysfunction, Coronary Artery Disease, Chronic Ischaemic Disease, Artrial Fibrillation and Flutter, Coronary Atherosclosis, Atheroscherosis Renal Arteries, Diabetes with Renal Manifestations, Mitral Valve Disorders, Aortic Valve Disorders, Tachycardia, Cardiac Dysrhythmias, Primary Cardiomyopathy, Metabolic Syndrome, Pulmonary Valve Disorder, Migraine, and Prevention of Migraine

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Wednesday, March 15, 2006
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.